| Literature DB >> 22312484 |
Sangita Revdiwala1, Bhaumesh M Rajdev, Summaiya Mulla.
Abstract
Background. Biofilms contaminate catheters, ventilators, and medical implants; they act as a source of disease for humans, animals, and plants. Aim. Critical care units of any healthcare institute follow various interventional strategies with use of medical devices for the management of critical cases. Bacteria contaminate medical devices and form biofilms. Material and Methods. The study was carried out on 100 positive bacteriological cultures of medical devices which were inserted in hospitalized patients. The bacterial isolates were processed as per microtitre plate. All the isolates were subjected to antibiotic susceptibility testing by VITEK 2 compact automated systems. Results. Out of the total 100 bacterial isolates tested, 88 of them were biofilm formers. A 16-20-hour incubation period was found to be optimum for biofilm development. 85% isolates were multidrug resistants and different mechanisms of bacterial drug resistance like ESBL, carbapenemase, and MRSA were found among isolates. Conclusion. Availability of nutrition in the form of glucose enhances the biofilm formation by bacteria. Time and availability of glucose are important factors for assessment of biofilm progress. It is an alarm for those who are associated with invasive procedures and indwelling medical devices especially in patients with low immunity.Entities:
Year: 2012 PMID: 22312484 PMCID: PMC3270516 DOI: 10.1155/2012/945805
Source DB: PubMed Journal: Crit Care Res Pract ISSN: 2090-1305
Relation of clinical bacterial isolates and the type of device inserted.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| Endotracheal tube | 16 | 17 | 13 | 7 | 3 | 1 | 1 | 1 |
| CVP tip | 2 | 0 | 2 | 0 | 0 | 5 | 1 | 1 |
| Foley's catheter tip | 1 | 3 | 1 | 3 | 1 | 0 | 1 | 0 |
| Abdominal drain tube | 1 | 1 | 0 | 3 | 0 | 2 | 0 | 0 |
| Nephrostomy tube | 2 | 0 | 2 | 0 | 0 | 1 | 0 | 0 |
| Tracheostomy tube | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| D.J. stent tip | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
| SPC tip | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
|
| ||||||||
| Total | 23 | 23 | 20 | 16 | 4 | 9 | 3 | 2 |
Screening of 100 bacterial isolates for biofilm formation by microtitre plate method in different media and at 16, 20, and 24 hr incubation periods.
| No. of isolates | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Biofilm formation (OD492–630 mm) | TSB | TSB, 0.25% glucose | TSB, 0.5% glucose | ||||||
| 16 hr | 20 hr | 24 hr | 16 hr | 20 hr | 24 hr | 16 hr | 20 hr | 24 hr | |
| High (ODc | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 |
| Moderate (2 × ODc < OD = 4 × ODc) | 17 | 24 | 19 | 19 | 18 | 17 | 15 | 21 | 17 |
| Weak (ODc | 39 | 43 | 44 | 44 | 49 | 43 | 33 | 32 | 30 |
Experiment was done in quadruplet and repeated two times. All OD492–630 mm values were expressed as average with standard deviation.
Different mechanisms of drug resistance in isolates of indwelling medical devices.
| Name of bacteria | ESBL | Carbapenemase | Alteration of PBP | Van A/B |
|---|---|---|---|---|
|
| 15 | 25 | ||
|
| 25 | 30 | ||
|
| 30 | 30 | ||
|
| 25 | 15 | ||
|
| 40 | 0 | ||
|
| 5 | 0 | ||
|
| 45 | |||
|
| 60 | 55 |
Quantitative analysis of biofilm production by clinical bacterial isolates as evaluated by microtitre plate method.
| Strong | Moderate | Weak | |
|---|---|---|---|
|
| 1 | 16 | 5 |
|
| 2 | 8 | 8 |
|
| 1 | 8 | 11 |
|
| 0 | 1 | 10 |
|
| 0 | 2 | 2 |
|
| 1 | 5 | 2 |
|
| 0 | 2 | 1 |
|
| 0 | 1 | 1 |
|
| |||
| Total | 5 | 44 | 39 |